Abstract
Background
Recently, we reported that the microRNAs (miRNAs) miR-20a-5p and—to a lesser extent—miR-222-3p hold potential as biomarkers for gestational diabetes mellitus (GDM) in human immunodeficiency virus (HIV)-negative South African women.
Methods
In this preliminary study, we measured the expression of these miRNAs in HIV-positive women (GDM 15, non-GDM 52; median 26.0 weeks; range 16–30).
Results
Although the same trend of decreased expression of miR-20a-5p (1.5-fold decrease) and miR-222-3p (1.4-fold decrease) was observed in sera of women with and without GDM, these differences were not statistically significant. Stratification according to antiretroviral treatment (ART) confirmed decreased expression of miR-20a-5p and miR-222-3p in ART-naïve and ART-treated women with GDM, although again this was not statistically significant.
Conclusion
Our results demonstrate that HIV infection modifies the expression of miR-20a-5p and miR-222-3p in women with GDM. Importantly, this study highlights the complexities of miRNA profiling and the need for GDM biomarker discovery in both HIV-infected and uninfected individuals, particularly in South Africa, where approximately 30% of pregnancies are complicated by HIV. Further studies to elucidate the mechanisms that underlie these miRNA differences are needed.
References
Ferrara A. Increasing prevalence of gestational diabetes mellitus. Diabetes Care. 2007;30(Suppl 2):S141. https://doi.org/10.2337/dc07-s206.
Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl 2):S112–9. https://doi.org/10.2337/dc07-s202.
International Diabetes Federation (2017) IDF Diabetes Atlas 8th edition. http://diabetesatlas.org/resources/2017-atlas.html. Accessed 10 Feb 2019.
Adam S, Rheeder P. Screening for Gestational diabetes mellitus in a South African population: prevalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J. 2017;107(6):523–7. https://doi.org/10.7196/SAMJ.2017.v107i6.12043.
Mitanchez D, Yzydorczyk C, Siddeek B, Boubred F, Benahmed M, Simeoni U. The offspring of the diabetic mother-short- and long-term implications. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):256–69. https://doi.org/10.1016/j.bpobgyn.2014.08.004.
Agarwal MM. Gestational diabetes mellitus: screening with fasting plasma glucose. World J Diabetes. 2016;7(14):279–89. https://doi.org/10.4239/wjd.v7.i14.279.
Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after Gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9. https://doi.org/10.1016/S0140-6736(09)60731-5.
Falavigna M, Schmidt MI, Trujillo J, et al. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract. 2012;98(3):396–405. https://doi.org/10.1016/j.diabres.2012.09.002.
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
Krek A, Grün D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495–500. https://doi.org/10.1038/ng1536.
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. https://doi.org/10.1016/j.cell.2004.12.035.
Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res J Lab Clin Med. 2011;157(4):253–64. https://doi.org/10.1016/j.trsl.2011.01.009.
Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110(3):483–95. https://doi.org/10.1161/CIRCRESAHA.111.247452.
Poirier C, Desgagné V, Guérin R, Bouchard L. MicroRNAs in pregnancy and Gestational diabetes mellitus: emerging role in maternal metabolic regulation. Curr Diab Rep. 2017;17(5):35. https://doi.org/10.1007/s11892-017-0856-5.
Rehle T, Johnson L, Hallett T, et al. A comparison of South African national HIV incidence estimates: a critical appraisal of different methods. PloS One. 2015;10(7):e0133255. https://doi.org/10.1371/journal.pone.0133255.
Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Investig. 2008;118(4):1244–54. https://doi.org/10.1172/JCI34706.
National Department of Health (2017) The 2015 National Antenatal Sentinel HIV and Syphilis Survey, South Africa.
Omar F, Dave JA, King JA, Levitt NS, Pillay TS. High molecular weight (HMW): total adiponectin ratio is low in HIV-infected women receiving protease inhibitors. BMC Clin Pathol. 2014;14(1):46. https://doi.org/10.1186/1472-6890-14-46.
Non LR, Escota GV, Powderly WG. HIV and its relationship to insulin resistance and lipid abnormalities. Transl Res. 2017;183:41–56. https://doi.org/10.1016/j.trsl.2016.12.007.
Pepin ME, Padgett LE, McDowell RE, et al. Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance. Mol Metab. 2018;12:48–61. https://doi.org/10.1016/j.molmet.2018.04.006.
Pheiffer C, Dias S, Rheeder P, Adam S. Decreased expression of circulating miR-20a-5p in South African women with Gestational diabetes mellitus. Mol Diagn Ther. 2018;22(3):345–52. https://doi.org/10.1007/s40291-018-0325-0.
Zhu Y, Tian F, Li H, Zhou Y, Lu J, Ge Q. Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2015;130(1):49–53. https://doi.org/10.1016/j.ijgo.2015.01.010.
Zhao C, Dong J, Jiang T, et al. Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One. 2011;6(8):e23925. https://doi.org/10.1371/journal.pone.0023925.
Balasubramaniam M, Pandhare J, Dash C. Are microRNAs important players in HIV-1 infection? An update. Viruses. 2018;10(3):110. https://doi.org/10.3390/v10030110.
Guha D, Mancini A, Sparks J, Ayyavoo V. HIV-1 infection dysregulates cell cycle regulatory protein p21 in CD4+ T cells through miR-20a and miR-106b regulation. J Cell Biochem. 2016;117(8):1902–12. https://doi.org/10.1002/jcb.25489.
Orecchini E, Doria M, Michienzi A, et al. The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222. RNA Biol. 2014;11(4):334–8. https://doi.org/10.4161/rna.28372.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. https://doi.org/10.2337/dc09-1848.
Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173–211. https://doi.org/10.1016/S0020-7292(15)30007-2.
National Department of Health (2015) National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Department of Health, Pretoria, South Africa. https://sahivsoc.org/Files/ART%20Guidelines%2015052015.pdf. Accessed 10 Feb 2019.
UNAIDS (2018) UNAIDS Fact Sheet. http://www.unaids.org/en/resources/fact-sheet. Accessed 11 Feb 2019.
Dias S, Hemmings S, Muller C, Louw J, Pheiffer C. MicroRNA expression varies according to glucose tolerance, measurement platform, and biological source. BioMed Res Int. 2017;1080157:1–10. https://doi.org/10.1155/2017/1080157.
Pheiffer C, Dias S, Willmer T, Pace R, Aagaard K, Louw J. Altered microRNA expression during impaired glucose tolerance and high-fat diet feeding. Exp Clin Endocrinol Diabetes. 2018. https://doi.org/10.1055/a-0619-4576.
Cao Y-L, Jia Y-J, Xing B-H, Shi D-D, Dong X-J. Plasma microRNA-16-5p, -17-5p and -20a-5p: novel diagnostic biomarkers for Gestational diabetes mellitus. J Obstet Gynaecol Res. 2017;43(6):974–81. https://doi.org/10.1111/jog.13317.
Wander PL, Boyko EJ, Hevner K, et al. Circulating early- and mid-pregnancy microRNAs and risk of Gestational diabetes. Diabetes Res Clin Pract. 2017;132:1–9. https://doi.org/10.1016/j.diabres.2017.07.024.
Tagoma A, Alnek K, Kirss A, Uibo R, Haller-Kikkatalo K. MicroRNA profiling of second trimester maternal plasma shows upregulation of miR-195-5p in patients with gestational diabetes. Gene. 2018;672:137–42. https://doi.org/10.1016/j.gene.2018.06.004.
Zheng S. The growing threat of China’s HIV epidemic. Lancet Public Health. 2018;3(7):e311. https://doi.org/10.1016/S2468-2667(18)30098-7.
Cai M, Kolluru GK, Ahmed A. Small molecule, big prospects: microRNA in pregnancy and its complications. J Pregnancy. 2017;2017:6972732. https://doi.org/10.1155/2017/6972732.
Shi Z, Zhao C, Guo X, et al. Differential expression of microRNAs in omental adipose tissue from Gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance. Endocrinology. 2014;155(5):1982–90. https://doi.org/10.1210/en.2013-2046.
Tsamou M, Martens DS, Winckelmans E, et al. Mother’s pre-pregnancy BMI and placental candidate miRNAs: findings from the ENVIRONAGE birth cohort. Sci Rep. 2017;7(1):5548. https://doi.org/10.1038/s41598-017-04026-8.
Qian K, Hu L, Chen H, et al. Hsa-miR-222 is involved in differentiation of endometrial stromal cells in vitro. Endocrinology. 2009;150(10):4734–43. https://doi.org/10.1210/en.2008-1629.
Dias S, Pheiffer C, Abrahams Y, Rheeder P, Adam S. Molecular biomarkers for gestational diabetes mellitus. Int J Mol Sci. 2018;19(10):E2926. https://doi.org/10.3390/ijms19102926.
Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord. 2008;6(2):87–102. https://doi.org/10.1089/met.2007.0029.
Richter EA, Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J. 2009;418(2):261–75. https://doi.org/10.1042/BJ20082055.
Jao J, Wong M, Van Dyke RB, et al. Gestational diabetes mellitus in HIV-infected and -uninfected pregnant women in Cameroon. Diabetes Care. 2013;36(9):e141–2. https://doi.org/10.2337/dc13-0968.
Soepnel LM, Norris SA, Schrier VJMM, et al. The association between HIV, antiretroviral therapy, and gestational diabetes mellitus. AIDS. 2017;31(1):113–25. https://doi.org/10.1097/QAD.0000000000001277.
Acknowledgements
The authors thank the volunteers who participated in the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Carmen Pheiffer, Stephanie Dias, Paul Rheeder, and Sumaiya Adam have no conflicts of interest that are directly relevant to the content of this article.
Funding
This work was funded by the South African Medical Research Council (C. Pheiffer) and the Society for Endocrinology, Metabolism and Diabetes in South Africa and the University of Pretoria (S. Adam).
Ethical approval and informed consent
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Pheiffer, C., Dias, S., Rheeder, P. et al. MicroRNA Profiling in HIV-Infected South African Women with Gestational Diabetes Mellitus. Mol Diagn Ther 23, 499–505 (2019). https://doi.org/10.1007/s40291-019-00404-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40291-019-00404-2